Increased susceptibility of TNF-α lymphotoxin-α double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1498-1505

  Netea, Mihai G ^a   Van Tits, Lambertus J H ^a   Curfs, Jo H A J ^a   Amiot, Franck ^b   Meis, Jacques F G M ^a   Van Der Meer, Jos W M ^a   Kullberg, Bart Jan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Unite Mixte de Recherche   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LYMPHOTOXIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE PREDISPOSITION; FUNGUS GROWTH; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; MOUSE; NEUTROPENIA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; BLOOD BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; CANDIDIASIS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; KIDNEY; LYMPHOTOXIN-ALPHA; MICE; MICE, KNOCKOUT; NEUTROPHILS; PHAGOCYTOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033178999     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Rex, J. H., J. E. Bennett, A. M. Sugar, P. G. Pappas, C. M. Van der Horst, J. E. Edwards, R. G. Washburn, W. M. Scheld, A. W. Karchmer, A. P. Dine, M. J. Levenstein, C. D. Webb, and Candidemia Study Group and National Institute of Allergy and Infectious Diseases Mycoses Study Group. 1994. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N. Engl. J. Med. 331:1325.
2. Beutler, B. E. 1992. Tumor Necrosis Factors: The Molecules and Their Emerging Roles in Medicine. Raven Press, New York.
3. Bazzoni, F., and B. Beutler. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1717.
4. Parillo, J. E., M. M. Parker, C. Natanson, A. F. Suffredini, R. L. Danner, R. E. Connion, and F. P. Ognobene. 1990. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 113:227.
5. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachexin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869.
6. Tracey, K. J., Y. Fong, D. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662.
7. Nakane, A., T. Minagawa, and K. Kato. 1988. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect. Immun. 56:2563.
8. Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, and P. Vassali. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731.
9. Echtenacher, B., W. Falk, D. N. Mannel, and P. H. Krammer. 1990. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145:3762.
10. Vecchiarelli, A., M. Puliti, A. Torosantucci, A. Cassone, and F. Bistoni. 1991. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. Cell. Immunol. 134:65.
11. Riipi, L., and E. Carlson. 1990. Tumor necrosis factor (TNF) is induced in mice by Candida albicans: role of TNF in fibrinogen increase. Infect. Immun. 58:2750.
12. Steinshamn, S., and A. Waage. 1992. Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect. Immun. 60:4003.
13. Netea, M. G., W. L. Blok, B. J. Kullberg, M. Bemelmans, M. T. E. Vogels, W. A. Buurman, and J. W. M. Van der Meer. 1995. Pharmacological inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J. Infect. Dis. 171:393.
14. Steinshamn, S., M. H. A. Bemelmans, L. H. J. Van Tits, K. Bergh, W. A. Buurman, and A. Waage. 1996. TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense. J. Immunol. 157:2155.
15. Kullberg, B. J. 1997. Trends in immunotherapy of fungal infections. Eur. J. Clin. Microbiol. Infect. Dis. 16:51.
16. Leijh, P. C. J., M. T. Van den Barselaar, and R. Van Furth. 1977. Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infect. Immun. 17:313.
17. Van't Wout, J. W., I. Linde, P. C. J. Leijh, and R. Van Furth. 1988. Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infections. Eur. J. Clin. Microbiol. Infect. Dis. 7:736.
18. Kullberg, B. J., J. W. Van't Wout, C. Hoogstraten, and R. Van Furth. 1993. Recombinant interferon-γ enhances resistance to acute disseminated Candida albicans infection in mice. J. Infect. Dis. 168:436.
19. Kullberg, B. J., M. G. Netea, J. H. A. J. Curfs, M. Keuter, J. F. G. M. Meis, and J. W. M. Van der Meet. 1998. Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in non-neutropenic mice. J. Infect. Dis. 177:175.
20. Djeu, J. Y., D. K. Blanchard, D. Halkias, and H. Friedman. 1986. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-γ and tumor necrosis factor. J. Immunol. 137:2980.
21. Ferrante, A. 1989. Tumor necrosis factor α potentiates neutrophil antimicrobial activity: increased fungal activity against Torulopsis glabrala and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect. Immun. 57:2115.
22. Amiot, F., O. Boussadia, S. Cases, C. Fitting, M. Lebastard, J.-M. Cavaillon, G. Millon, and F. Dautry. 1997. Mice heterozygous for a deletion of the tumor necrosis factor-α and lymphotoxin-α genes: biological importance of a nonlinear response of tumor necrosis factor-α to gene dosage. Eur. J. Immunol. 27:1035.
23. Lehrer, R. I., and M. J. Cline. 1969. Interactions of Candida albicans with human leukocytes and serum. J. Bacteriol. 98:996.
24. Kullberg, B. J., J. W. Van't Wout, and R. Van Furth. 1990. Role of granulocytes in enhanced host resistance to Candida albicans induced by recombinant interteukin-1. Infect. Immun. 58:3319.
25. Van't Wout, J. W., I. Linde, P. C. J. Leijh, and R. Van Furth. 1989. Effect of irradiation, cyclophosphamide, and etoposide (VP-16) on number of peripheral blood and peritoneal leukocytes in mice under normal conditions and during acute inflammatory reaction. Inflammation 13:1.
26. Kullberg, B. J., J. W. Van't Wout, and R. Van Furth. 1991. No effect of recombinant human interleukin-1 on the numbers of peripheral blood and peritoneal leukocytes during an acute inflammation. Inflammation 15:457.
27. Balow, J. E. 1975. Cyclophosphamide suppression of established cell-mediated immunity. J. Clin. Invest. 56:65.
28. Amiot, F., Y. Bellkaid, M. Lebastard, P. Ave, F. Dautry, and G. Milon. 1996. Abnormal organization of the splenic marginal zone and the correlated leukocytosis in lymphotoxin-α and tumor necrosis factor-α double deficient mice. Eur. Cytokine Netw. 7:733.
29. Lundqvist, H., and C. Dahlgren. 1996. Isoluminol-enhanced chemluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic. Biol. Med. 20:785.
30. Netea, M. G., P. N. M. Demacker, B. J. Kullberg, O. C. Boerman, I. Verschueren, A. F. H. Stalenhoef, and J. W. M. Van der Meer. 1996. Low-density-lipoprotein receptor deficient mice are protected against lethal endoloxinemia and severe Gram-negative infections. J. Clin. Invest. 97:1366.
31. Amiot, F., C. Fitting, K. J. Tracey, J. M. Cavaillon, and F. Dautry. 1997. Lipopolysaccharide-induced cytokine cascade and lethality in lymphotoxin-α/tumor necrosis factor-α deficient mice. Mol. Med. 3:864.
32. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561.
33. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkemagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798.
34. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L monocytogenes infection. Cell 73:457.
35. Yap, G. S., T. Scharton-Kersten, H. Charest, and A. Sher. 1998. Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. J. Immunol. 160:1340.
36. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, S. Basu, and L. J. Old. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093.
37. Lo, H.-J., J. R. Kohler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939.
38. Peschon, J. J., D. S. Torrance, K. L. Stocking, M. B. Glaccum, C. Otten, C. R. Willis, K. Charrier, P. J. Morrissey, C. B. Ware, and K. M. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:943.
39. Loftus, J. C., and R. C. Liddington. 1997. New insights into integrin-ligand interaction. J. Clin. Invest. 99:2302.
40. Kansas, G. S. 1996. Selectins and their ligands: current concepts and controversies. Blood 88:3259.
41. Ward, P. A. 1997. Recruitment of inflammatory cells into lung: roles of cytokines, adhesion molecules, and complement. J. Lab. Clin. Med. 129:400.
42. Neumann, B., T. Machleidt, A. Lifka, K. Pfeffer, D. Vestweber, T. W. Mak, B. Holzmann, and M. Kronke. 1996. Crucial role for 55-kilodalton receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J. Immunol. 156:1587.
43. Forsyth, C. B., and H. L. Mathews. 1996. Lymphocytes utilize CD11b/CD18 for adhesion to Candida albicans. Cell. Immunol. 170:91.
44. Davis, S. L., E. P. Hawkins, E. O. Mason, C. Wayne Smith, and S. L. Kaplan. 1996. Host defenses against disseminated candidiasis are impaired in intercellular adhesion molecule 1-deficient mice. J. Infect. Dis. 174:435.
45. Vieira, L. Q., M. Goldschmidt, M. Nashleanas, K. Pfeffer, T. Mak, and P. Scott. 1996. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J. Immunol. 157:827.
46. Romani, L. 1997. The T cell response against fungal infections. Curr. Opin. Immunol. 9:484.
47. Mencacci, A., E. Cenci, G. Del Sero, C. Fe d'Ostiani, P. Mosci, P. Montagnoli, A. Bacci, F. Bistoni, V. F. Quesniaux, B. Ryffel, and L. Romani. 1998. Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-α double-deficient mice infected with Candida albicans. Int. Immunol. 10:37.
48. Granowitz, E. V., E. Vannier, D. D. Poutsiaka, and C. A. Dinarello. 1992. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis. II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes. Blood 79:2364.
49. Muhl, H., and C. A. Dinarello. 1997. Macrophage inflammatory protein-1α production in lipopolysaccharide-stimulated human adherent blood mononuclear cells is inhibited by the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine. J. Immunol. 159:5063.
50. Pasparakis, M., L. Alexopoulou, V. Episcopou, and G. Kollias. 1996. Immune and inflammatory responses in TNFα-deficient mice; a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397.
51. Van der Meer, J. W. M. 1989. Options for the treatment of serious infections with interieukin-1. Biotherapy 1:313.
52. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 183:1345.